Biomarker Conferences

Biomarker Conferences | Personalized Medicine Conferences

Is your meeting listed?

Submit a conference announcement

Prenatal Molecular Diagnostics Europe

The Prenatal Molecular Diagnostics Europe conference, presented by Cambridge Healthtech Institute, aims to take an in-depth look at the current trends and guidelines in Europe for prenatal molecular diagnostics, while providing perspectives on how this rapidly changing field is likely to develop in Europe over the next several years. In addition to the technical issues there are a number of other factors, including geographic differences, coverage of diagnostic tests from one country to another, challenges of clinical implementation of new procedures, and the increased need for genetic counseling perspectives, that need to be understood in order to forecast how this field is likely to develop in Europe.

May 12-13, 2014, Lisbon, Portugal

ICBCM 2014 : International Conference on Biomarkers and Clinical Medicine

The ICBCM 2014: International Conference on Biomarkers and Clinical Medicine, presented by the World Academy of Science, Engineering and Technology, aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Biomarkers and Clinical Medicine. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Biomarkers and Clinical Medicine.

May 19-20, 2014, Paris, France

3rd Tumor Models to Guide Targeted Cancer Therapy and Drug Development

The 3rd annual Tumor Models to Guide Targeted Cancer Therapy and Drug Development conference, presented by Cambridge Healthtech Institute, aims to bring together cancer researchers and clinicians working on development of molecularly targeted cancer therapies, and to initiate a knowledge exchange around preclinical models and their optimization. Highly characterized patient-derived tumor tissue xenograft models that allow us to more effectively evaluate novel targeted therapeutics as well as to identify predictive biomarkers in early stages of drug development will be discussed. Case studies and solutions for increasing the reproducibility and predictability of preclinical cancer studies will be presented.

May 21-22, 2014, Boston, MA, USA

Precision Diagnostics Summit

As personalized medicine integrates into clinical practice, genomic tools and technologies will need to evolve to meet the increasing test volume and required accuracy. Cambridge Healthtech Institute’s Precision Diagnostics Summit will provide a start-to-finish look at the latest methods for sample preparation, novel tools for nucleic acid detection, and final analysis of results.

June 16-18, 2014, Boston, MA, USA

Next Generation Dx Summit

Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit, presented by Cambridge Healthtech Institute, will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell free DNA and single cell sequencing.

August 19-21, 2014, Washington, DC, USA

Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change

Tumor collections provide insight into the great variability of cancer, its progression and its response to treatment. Recent advancements in high-throughput genomics, proteomics and other -omics platforms allow profiling of large numbers of cancer analytes in a single assay. Data collection and analysis allow researchers to link and integrate information and determine variations in cancer molecular profiles. Knowledge of these altered molecular landscapes offers great promise for developing molecular tests to improve diagnosis and optimize treatment. Cambridge Healthtech Institute’s Inaugural Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change convenes international oncology experts in the fields of tumor biospecimen research, molecular diagnostics/prognostics and pharmacogenomics.

September 15-17, 2014, Seattle, WA, USA

3rd Digital PCR Conference: Technologies and Tools for Precision Diagnostics

Digital PCR’s ability to precisely quantitate, identify mutations, copy number variations, and do gene expression analysis is creating waves across the diagnostics landscape. It is well suited for single-cell analysis and shows promise to become a superior tool in the clinic due to its capacity to work with small amounts of sample. The Third Annual Digital PCR event will bring together industry visionaries and early adopters to discuss digital PCR’s capabilities, limitations, and future applications. Researchers will examine applications in cancer biomarker and rare mutation detection, non-invasive fetal DNA analysis, and infectious disease quantification, particularly in HIV. Novel digital PCR devices from startups and academic labs will be showcased. Other topics to be addressed include digital PCR integration with existing technologies, solutions for processing difficult samples as well as increasing sample throughput, and guidelines and best practices for digital detection.

October 6-8, 2014, La Jolla, CA, USA

Biomarker Summit Europe 2014

The Biomarker Europe Summit 2014, presented by GTC (Global Technology Community), will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.

October 8-9, 2014, Berlin, Germany

4th Munich Biomarker Conference 2014

The Munich Biomarker Conference is organized by the networking agency BioM and brings together international experts from biotech and pharma industry with scientists and physicians. The programme covers all stages of biomarker development, from basic research to personalized treatment of patients. A focus lies on the translation of academic research findings into industry-driven drug development. A second core topic is the realization of individualized treatment in the standard of care. How can clinical processes, data management and reimbursement be adjusted to unleash the potential of personalized medicine? Strategies to overcome current limitations and possible solutions are discussed.

Nov 25-26, 2014, Munich, Germany

10th Annual Biomarkers Congress 2015

The Biomarkers Congress, presented by Oxford Global Conferences, will cover the latest advances in biomarker discovery and verification, including multiplex platforms, nanotechnology platforms and multiple reaction monitoring. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, systems biology approaches and better sample management. In the Companion Diagnostics stream, presentations will cover Rx/Dx co-development, methods to increase predictive significance and regulatory considerations.

Feb, 2015, Manchester, UK

Past Conferences

Reverse chronological order

Biomarkers & Diagnostics World Congress 2014

The Tenth Annual Biomarkers & Diagnostics World Congress 2014, presented by Cambridge Healthtech Institute, is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers-making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.

April 30-May 2, 2014, Philadelphia, PA, USA

2nd Biomarker Meeting in Personalized Reproductive Medicine

The aim of the 2nd Biomarker Meeting in Personalized Reproductive Medicine meeting, presented by ComtecMed, is to provide the human reproductive field state of the art developments in personalized medicine. We will do so by using novel technologies that allow us to improve our clinical success, using biomarkers for the majority of steps in the reproductive process and beyond in pregnancy. The participants will be informed of the existing and rapidly developing diagnostic technologies [deep-sequencing, genomics, transcriptomics, proteomics and metabolomics], which may help us better assess ovarian reserve, gametes, embryos and endometrium in order to increase success in our clinical procedures. Also the pathological implications and biomarkers implicated in each of these processes will be carefully analyzed.

April 10-12, 2014, Valencia, Spain

Circulating Biomarkers 2014

The 2nd annual Circulating Biomarkers Conference, presented by SELECTBIO, brings together academic researchers, clinician-scientists, as well as researchers from companies all focusing on various classes of biomarkers. Also, this event is an excellent meeting place for business development and marketing professionals from companies seeking to network with top-tier researchers from world-leading institutions.

March 24-25, 2014, Boston, MA, USA

Cancer Biomarkers Conference 2014

The 2014 Cancer Biomarkers Conference will be held March 22, 2014 at Houston Methodist Research Institute in the Texas Medical Center. Pathologists and oncologists require updated knowledge in the rapidly developing field of biomarkers to offer the best patient care. This one-day conference will provide a timely overview of predictive biomarkers in major solid tumors and biomarker reporting, oriented toward practical clinical application for pathologists, oncologists and others who care for cancer patients.

March 22, 2014, Houston, TX, USA

Biomarker Summit 2014

The Biomarker Summit 2014, presented by GTC (Global Technology Community), is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification and validation strategies, bioinformatics and systems biology approaches to personalized medicine, big data management, regulatory and reimbursement trends, companion diagnostics development, and, finally, funding and investment opportunities. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

March 19-21, 2014, San Diego, CA, USA

microRNA as Biomarkers and Diagnostics

For the 3rd time, the ISOBM organizes the 41th Meeting of the International Society of Oncology and Biomarkers (ISOBM) simultaneously to the XIV International Symposium on Biology and Clinical Usefulness of Tumor Markers.

March 15-18, 2014, Barcelona, Spain

microRNA as Biomarkers and Diagnostics

The tenth annual microRNA as Biomarkers and Diagnostics conference, presented by Cambridge Healthtech Institute, will cover the latest developments in the use of microRNA in the early detection of disease for more effective treatment, monitoring tumor growth and disease progression, issues associated with microRNA measurement, and the potential for personalized medicine based on microRNA profile.

March 17-18, 2014, Boston, MA, USA

9th Annual Biomarkers Congress 2014

The Biomarkers Congress, presented by Oxford Global Conferences, will cover the latest advances in biomarker discovery and verification, including multiplex platforms, nanotechnology platforms and multiple reaction monitoring. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, systems biology approaches and better sample management. In the Companion Diagnostics stream, presentations will cover Rx/Dx co-development, methods to increase predictive significance and regulatory considerations.

Feb 25-26, 2014, Manchester, UK

11th Partnering with Central Labs, Biomarker and Specialty Labs

The 11th Annual Partnering with Central Labs, Biomarker and Specialty Labs 2014 conference, presented by Informa Life Sciences, provides practical case studies and real life examples of how pharma and biotech companies, and CROs can be optimising partnerships with central, biomarker and specialty labs for improved efficiency and reliability in outsourcing clinical lab services.

Feb 25-26, 2014, London, UK

Circulate: Circulating Cancer Biomarkers

Circulate, presented by Hanson Wade, will provide you with the latest clinical studies in the field, giving you access to the unpublished data and initial evaluation of how circulating biomarkers are performing. Understand how you can harness circulating biomarkers as powerful diagnostic tools and gain an exclusive industry perspective on the near-future outlook for this promising field.

Feb 18-20, 2014, Berlin, Germany

Biomarker Europe Summit 2013

The summit, presented by GTC (Global Technology Community), will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector. The summit will consist of two co-located conferences that will focus on different stages of biomarker development: Biomarkers in Drug Discovery & Development and Biomarkers in Diagnostics.

Oct 9-10, 2013, Berlin, Germany

Global Biomarkers Consortium

The Global Biomarkers Consortium, presented by Core Principle Solutions, is the only global meeting dedicated to advancing the understanding of value and clinical impact of biomarker research in oncology. Guided by the expertise of leaders in this field, participants will receive a thorough understanding of the current and future landscape of the relevance of tumor biomarkers and how to effectively personalize cancer care in the clinical setting.

Oct 4-6, 2013, Boston, Massachusetts, USA

5th annual Molecular Dx: Cancer Drug Development

The 5th annual Molecular Dx: Cancer Drug Development, presented by Hanson Wad, will teach you how to apply the game changing techniques that are accelerating the development of personalized cancer treatment. Up to date clinical results and real-world case studies from your peers give you the clearest route to success in personalized cancer drug development. Two conference streams allow you to truly personalize your agenda, to make sure you get the most out of the 2 days. One stream tackles the fundamentals of biomarker development and clinical trial optimization. The other focuses on the most up to date techniques driving MDx.

June 18-20, 2013, Boston, Massachusetts, USA

Ninth Annual Biomarkers & Diagnostics World Congress 2013

The Ninth Annual Biomarkers & Diagnostics World Congress 2013, presented by Cambridge Healthtech Institute, is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting place to share experiences, foster collaborations across industry and academia, and evaluate emerging technologies. The program is expanded this year to include cutting-edge coverage of diagnostics, including clinical assay development, companion diagnostics, regulatory compliance, tissue diagnostics, and exosome biomarkers.

May 6-8, 2013, Philadelphia, Pennsylvannia, USA

GTC Biomarker Summit 2013

The Biomarker Summit 2013, presented by GTC (Global Technology Community), assembles leading scientists, researchers, decision-makers and other players across the industry spectrum, and provides a unique opportunity to gain the latest biomarker developments in three major therapeutic areas, formally organized in the following three tracks: (1) oncology biomarkers; (2) neurological biomarkers; and (3) inflammatory & immunological biomarkers. The summit will discuss a wide range of issues such as biomarker identification and validation strategies, patient stratification, enabling omics technologies, bioinformatics and systems biology techniques, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Mar 20 – 22, 2013, San Francisco, California, USA

World CDx Frankfurt

The World CDx Frankfurt, presented by Hanson Wade, brings you exclusive insights, novel case studies and cutting-edge solutions from those at the forefront of personalized medicine. Recent developments in the field have highlighted incredible opportunities as well as numerous hurdles associated with CDx development, including: finding the best path to commercialization, translating biomarkers in the clinic into effective diagnostics, and determining the best routes to market adoption and drug pipeline enhancement. By learning how to form the most effective partnerships, enhancing your own CDx commercial strategies to overcome market access hurdles and reducing clinical attrition by harnessing the most cutting edge techniques and technologies, your organization can take advantage of the huge potential of companion diagnostics.

Mar 19 – 21, 2013, Frankfurt, Germany

ERPs Biomarkers Clinical Conference 2013

This conference will bring together some of the leading national and international experts in clinical application of EEG Brain Diagnostics and Event Related Potentials for understanding brain function and dysfunction in clinical practice of mental and neurological health. This forum will provide an opportunity to exchange knowledge of the advanced methodologies available in this field and also foster practical skills in their application.

Mar 16, 2013, Gold Coast, Australia

The eighth annual Biomarkers Congress 2013

The 8th Annual Biomarkers Congress 2013 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 250 attendees to gain knowledge and insights into the Biomarkers marketplace from over 55 presentations/roundtables/panel discussions in four interactive streams: biomarker discovery & validation strategies and regulation; companion diagnostics and personalized medicine; safety and biomarkers In clinical development; enabling technologies to maximize biomarker identification.

Feb 19 – 20, 2013, Manchester, UK

Molecular Med TRI-CON 2013

Celebrating 20 years of advancing applied science and technology, the Molecular Med TRI-CON, presented by Cambridge Healthtech Institute, will take place at the Moscone North Convention Center in San Francisco, California. Several tracks focus on biomarkers and/or personalized medicine:

  1. Companion Diagnostics, Feb 13-15
  2. Cancer Molecular Markers, Feb 13-15
  3. Personalized Diagnostics, Feb 13-15
  4. Molecular Diagnostics, Feb 13-15
  5. Integrated R&D Informatics and Knowledge Management, Feb 13-15
  6. Bioinformatics in the Genome Era, Feb 13-15

Feb 11-15, 2013, San Francisco, California, UAS

Biomarkers for Brain Disorders: Challenges and Opportunities

The 2nd Wellcome Trust Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities will once again bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs.

Feb 3-5, 2013, Cambridge, UK

The second Biomarker Discovery Conference (BDC 2012)

The 21st century has seen a revolution in biology and medicine that will radically change the way we monitor health and diagnose disease. Central to this revolution: a multidisciplinary approach to the evolving science of biomarker discovery and identification. The second Biomarker Discovery Conference (BDC 2012) showcases the latest innovations in Biomarker Discovery using genomic, proteomic and metabolomic tools and methods.

Dec 3-6, 2012, Port Stephens, New South Wales, Australia

World CDx Boston

The World CDx Boston, presented by Hanson Wade, brings you exclusive insights, novel case studies and cutting-edge solutions from those at the forefront of personalized medicine. This unique collection of industry leaders will address the most pressing challenges, both at lab-phase and at market level, with companion diagnostic development. You will leave the meeting with the tools and knowledge you need to reduce clinical attrition, achieve successful commercialization and claim your place as a CDx market leader.

Nov 12-15, 2012, Boston, MA, USA

2nd Annual Oncology Biomarkers Congress

The 2nd Oncology Biomarkers Congress, presented by Oxford Global, is co-located with the Oncology Clinical Development Congress. Over two days, the event provides a first class educational and networking opportunity for over 150 attendees to gain knowledge and insights into the Oncology biomarkers market. The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.

Oct 10 – 11, 2012, Manchester, UK

Biomarkers 2012: Successful Strategies & Developments in Biomarkers

Biomarkers 2012, organized by Virtue Insight, equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities.

September 26, 2012, London, UK

Cambridge Healthtech Institute’s Fourth Annual Biomarker Discovery Informatics 2012

Cambridge Healthtech Institute’s Biomarker Discovery Informatics conference — ADAPT Congress — will bring together key players in the process of biomarker discovery – from early stage pharmaceutical research organizations, to late stage clinical trials organizations, as well as NIH and NIST – in an effort to address the informatics and organizational challenges inherent in the development of personalized and clinically relevant biomarkers. Challenges and solutions to identifying genomic and proteomic biomarkers will be discussed. Advanced data mining techniques for exhaustive analysis of biomarker data will be presented.

September 19-21,2012, Washington DC

WIN 2012 Symposium: Efficacy of Biomarkers and Personalized Cancer Therapeutics

The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The WIN 2012 Symposium provides an open forum for discussion between all stakeholdere in cancer biomarkers and therapeutics development and great networking opportunities for everyone involved in improving cancer patient care at the level of the individual patient. The main theme of the 2012 symposium, Efficacy of biomarkers and personalized cancer therapeutics, will be elaborated in various plenary sessions, bringing together a unique assembly of high-ranking experts from academia, industry and regulatory agencies word wide as speakers and moderators.

June 29 – 29, 2012, Paris, France

Molecular Diagnostics for Cancer Drug Development

Molecular Diagnostics for Cancer Drug Development, presented by Hanson Wade, has become the must-attend forum for cancer and diagnostic professionals trying to navigate the biomarker-driven oncology drug development space. This event will profile those at the cutting-edge of personalized medicine in oncology to give you a thorough review of end to end drug and diagnostic development from discovery to commercialization, including the regulatory environment, pharma/biotech strategies and emerging technologies.

June 26 – 28, 2012, Boston, Massachusetts, USA

Biomarkers World Europe

The Biomarkers World Europe Conference, organized by Health Network Communications, gathers biomarker professionals together to answer the all important question — how can we get biomarkers to add value? How do you develop new medicines which demonstrate real value through predictable outcomes in targeted patient groups? The event is a two day strategic conference tackling these questions and providing participants with a thorough review of the use of biomarkers, their effectiveness and their potential to transform R & D.

May 22-24, 2012, London, UK

Biomarker World Congress 2012

The Biomarker World Congress 2012 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers — making the Congress a perfect meeting place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers. Now in its seventh year, the Biomarker World Congress is the leading annual meeting dedicated to biomarker research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.

May 21 – 23, 2012, Philadelphia, Pennsylvania, USA

2nd Annual Biomarkers in Diagnostics & Therapeutics (BDT2012)

The 2nd Annual BDT2012, presented by Event Protocol, brings together leaders from the diagnostic, pharmaceutical, medical and academic fields to evaluate developments in biomarker research and development. Areas of focus include companion diagnostics, clinical drug development and personalized treatment options. Key hurdles in biomarker identification and validation will be discussed, and new technological solutions, research targets and discovery strategies aiding in the translation of biomarkers to the clinic will be critically examined.

Apr 25 – 26, 2012, Singapore

The 1st Biomarker Meeting in Reproductive Medicine: Emergence of a New Field

The aim of the meeting, organized by Comtecmed, is to provide the Assisted Reproduction Technologies (ART) community an update of the fast approaching novel technologies that may allow for improved assessment using biomarkers of the reproductive potential of gametes, embryos, and endometrium.

Mar 30-31, 2012, Valencia, Spain

Biomarker Summit 2012

The Biomarker Summit 2012, presented by GTC (Global Technology Community), assembles leading scientists, researchers, decision-makers and other players across the industry spectrum. The Summit provides a unique opportunity to gain the latest biomarker developments in diagnostics, oncology and the business of biomarkers. The Summit’s four tracks allows attendees to engage in individual programs – or portions of all tracks – while enjoying networking opportunities with all attendees, speakers, poster presenters and exhibitors: 6th Biomarker Development Conference; Biomarkers & Diagnostics Conference; 4th Oncology Biomarker Conference; Biomarker Partnering & Deal-Making Conference. This truly one-of-a-kind, single-stop event has been carefully developed to provide insights into critical issues, discoveries, developments and investments from the most respected names within the biomarker industry.

March 15 – 16, 2012, San Diego, California, USA

The Global Biomarkers Consortium (GBC) 2012 Conference

The Global Biomarkers Consortium (GBC) is a community of world-renowned healthcare professionals that will convene in multiple educational forums to better understand the clinical application of predictive molecular biomarkers and advanced personalized care for patients. This conference is designed to educate physicians specializing in hematology/oncology, pathology and genetics on the state-of-the-art advances in our understanding of tumor biomarkers and their use in the clinical management of a variety of solid tumors and hematologic malignancies.

Mar 10 – 11, 2012, Orlando, Florida, USA

CNS Biomarkers Congress 2012

The CNS Biomarkers Congress 2012 presented by Oxford Global Conferences, co-located with the 7th Annual Biomarkers Congress, will provide the opportunity for two days worth of in depth analysis and insight into the maturing CNS Biomarkers market. Attend over twenty CNS specific presentations, roundtable and panel discussion sessions that will explores key issues such as CNS biomarker case studies in AD, PD, epiliepsy and MS; support of CNS drug development using biomarkers; challenges in CNS biomarkers; CSF biomarkers; neuroimaging; anti-amyloid therapies for AD; and technology case studies for CNS.

Feb 21 – 22, 2012, Manchester, UK

7th Annual Biomarkers Congress 2012

The 7th Annual Biomarkers Congress 2012 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 250 attendees to gain knowledge and insights into the Biomarkers marketplace. The conference consists of 55 presentations/roundtables/panel discussions and four interactive streams: biomarker discovery & validation strategies and regulation; companion diagnostics and personalized medicine; safety and biomarkers in clinical development; and enabling technologies to maximize biomarker identification.

Feb 21 – 22, 2012, Manchester, UK

3rd Annual Quest Diagnostics Biomarker Symposium

The half-day, complimentary symposium to the 7th Annual Biomarkers Congress 2012 (below), provides insights on how you can streamline your R&D process and identify potential cost savings through successful biomarker discovery, validation and clinical development.

Feb 20, 2012, Manchester, UK

4th Annual Biomarker Assay Development

Cambridge Healthtech Institute’s 4th annual biomarker assay development meeting addresses “fit-for-purpose” method development, spanning pre-clinical and clinical drug development, as well as diagnostics. The meeting will provide an overview of novel assay platforms for genomic and proteomic analysis, as well as multiplexed assays, flow cytometry, and biomarker assays in oncology. The biomarker assay development meeting will also address the pros and cons of developing the assay in-house vs. adopting off-the-shelf solutions/kits vs. outsourcing.

Jan 31 – Feb 1, 2012, San Diego, California, USA

Biomarkers and Brain Imaging of Presymptomatic Alzheimer’s Disease: Exploring the Silent Years

This symposium, presented by the New York Academy of Sciences, focuses on biomarkers and brain imaging of presymptomatic Alzheimer’s disease abd will explore an integrated view of the structural, functional, and biochemical events that may precede and predict both AD and amnestic mild cognitive impairment (aMCI).

January 26, 2012, New York, New York, USA

5th Annual Biomarkers Summit

The 5th annual biomarkers summit presented by SMi will provide a unique opportunity for debate and problem solving for key challenges facing the biomarkers fields and will present a fantastic platform for networking with senior executives from the pharmaceutical industry. It will give attendees the chance to hear about the latest developments and insights from industry leaders, and contribute to the discussion. The conference aims to provide a complete picture of developments in the biomarkers field, looking at biomarker development, discovery validation, as well as technological and regulatory updates and advice. Progress of research into therapeutic areas such as diabetes, oncology, immunology and neurodegenerative & respiratory diseases will also be discussed.

Jan 16 – 17, 2012, London, UK

4th World Companion Diagnostics Summit

The 4th World Companion Diagnostics Summit, presented by Hanson Wade, is designed to help attendees turn biomarker research into successful patient stratification and to deliver better, safer drugs to market with drug-diagnostic co-development.

Nov 28 – Dec 1, 2011, Boston, Massachusetts, USA

Translational Biomarkers in Diagnostics and Therapeutics

Organized by the Institute for Strategic Biotechnology, Health & Training (ISBHT), the key objective of this interactive workshop is to facilitate thoughtful exchanges between the key Indian stakeholders and those participating from the US.

Nov 16-18, 2011, Mumbai, India

Biomarker Applications for Improved Clinical Trial Outcomes

Biomarker Applications For Improved Clinical Trial Outcomes, presented by the Institute for International Research (IIR), is a must attend event to find out how to fully integrate your drug pipeline’s diagnostic needs with your trial design methods. By reconsidering how you structure and monitor partnerships between drug developers and diagnostics manufacturers, you can ensure availability of these diagnostics from the very outset of the trial process so they convey the greatest benefits.

November 15 – 16, 2011, Boston, Massachusetts, USA

2nd Annual Congress of Biomarkers (WCB-2011)

The 2nd Annual Congress of Biomarkers, Making Direct Bioanalysis Nimble, presented by BIT is an integral event of international collaboration for leaders in biomarkers and in major disease treatment. WCB-2011 is a platform to learn about the Chinese market, network with other delegates, deliver new products and advance understanding of the potential of new biomarker technologies.

November 14 – 16, 2011, Beijing, China

Using Biomarkers to Shorten Clinical Development Cycles

Using Biomarkers to Shorten Clinical Development Cycles conference, presented by ExL Pharma, provides attendees with unique take-home examples, case studies and multiple clinical development strategies to assist in shortening clinical phases, reducing costs, increasing approval rate, and time to market on in demand future drug products.

Nov 10-11, 2011, Arlington, Virginia, USA

2011 IEEE International Conference on Bioinformatics and Biomedicine (BIBM11)

IEEE BIBM 2011 will provide a general forum for disseminating the latest research in bioinformatics and biomedicine. It is a multidisciplinary conference that brings together academic and industrial scientists from computer science, biology, chemistry, medicine, mathematics and statistics. BIBM will exchange research results and address open issues in all aspects of bioinformatics and biomedicine and provide a forum for the presentation of work in databases, algorithms, interfaces, visualization, modeling, simulation, ontology and other computational methods, as applied to life science problems, with emphasis on applications in high throughput data-rich areas in biology, biomedical engineering. IEEE BIBM 2011 intends to attract a balanced combination of computer scientists, biologists, biomedical engineers, chemist, data analyzers and statisticians.

Nov 12 – 15, 2011, Atlanta, Georgia, USA

Paper deadline: July 15, 2011 Poster deadline: October 5, 2011

GTC 5th Biomarker Discovery & Development Conference

GTC’s 5th Annual Biomarker Discovery and Development Conference will present a host of distinguished speakers who will address topics that span the past, present and future of biomarker research. By taking a comprehensive look at the progress that has already been made, we will be able to make projections into the future regarding the ultimate development of personalized medicine. The discussions will begin with an overview of novel technologies used in biomarker discovery, followed by how these approaches are being utilized to streamline the development process by reducing time and costs, as well as minimizing drug attrition associated with safety concerns. The discussions will then culminate with topics including biomarker utility and clinical trials as companion diagnostics in the clinics.

Oct 19 – 21, 2011, San Diego, CA, USA

Biomarkers in Clinical Trials

The 3rd annual SMi conference on Biomarkers in Clinical Trials aims to explore the use of biomarkers in Cancer drug development.

Sep 19 – 20, 2011, London, UK

2nd World Congress on Biomarkers & Clinical Research

OMICS Publishing Group’s Biomarkers-2011 will schedule and coordinate all sessions with our Editorial Board Members of Journal of Molecular Biomarkers & Diagnosis and Journal of Postgenomics: Drug & Biomarker Development and other experts in the field. Biomarkers-2011 will serve as a catalyst for the advances in Biomarkers & Clinical Research studies by connecting scientists within and across disciplines at sessions and exhibition held at the venue, creates an environment conducive to information exchange, generation of new ideas, and acceleration of applications that benefit Pharmaceutical Industry.

Sep 12 – 14, 2011, Baltimore, Maryland, USA

Cambridge Healthtech Institute’s Inaugural Biomarker Discovery Informatics

Cambridge Healthtech Institute’s Biomarker Discovery Informatics conference will bring together key players in the process of biomarker discovery – from early stage pharmaceutical research organizations, to late stage clinical trials organizations, as well as NIH and NIST – in an effort to address the informatics and organizational challenges inherent in the development of personalized and clinically relevant biomarkers. Challenges and solutions to identifying genomic and proteomic biomarkers will be discussed. Advanced data mining techniques for exhaustive analysis of biomarker data will be presented.

Sep 8 – 9, 2011, Philadelphia, PA, USA

Abstract deadline: August 3, 2011

WORLDDx Congress

Delivering practical strategies for biomarker improvement and patient stratification, WORLDx Congress will help you respond to rapidly evolving regulations, changing reimbursement paradigms, and the alliance management scenarios unique to the diagnostics industry. Here you can build a solid infrastructure of reliable partnerships and commercialization mechanisms, in order to put your research and discovery technology to use in the most practical and profitable manner.

July 18 – 20, 2011, Baltimore, MD, USA

European Biomarkers Summit

Agenda topics include disease specific biomarkers, biomarkers in genomics, metabolomics and translational medicine, molecular diagnostics, personalized medicine and pharmacodiagnostics, and biomarker assay development. The conference will be co-located with Molecular Diagnostics Europe, Single Cell Analysis Congress and Theranostics for Personalised Medicine; registered delegates will also have access to these meetings ensuring a very cost-effective trip.

May 18 – 19, 2011, London, UK

Biomarkers World Europe

Europe’s largest gathering of biomarker professionals who will come together to answer the all important question- how can we get biomarkers to add value? It is a two day strategic conference which will provide participants with a thorough review of the use of Biomarkers, their effectiveness and their potential to transform R & D.

May 17 – 20, 2011, London, UK

Biochemical Markers of Brain Damage (BMBD) 2011

BMBD 2011 has scientific priorities in pediatric and adult head injury, stroke, neuroprotection and novel biomarkers. We expect to see several reports on the clinical use of biomarkers along with follow-up reports of novel biomarkers that were presented at BMBD 2009. We will have several specially-invited distinguished researchers presenting their work and we feel the scientific faculty includes most of the foremost international experts in the brain biomarker field.

May 9 – 11, 2011, Lund, Sweden

Biomarker World Congress

The Biomarker World Congress 2011 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers — making the Congress a perfect meeting place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers. Now in its seventh year, the Biomarker World Congress is the leading annual meeting dedicated to biomarker research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.

May 2 – 4, 2011, Philadelphia, Pennsylvania, USA

San Francisco Translational & Biomarker Research Symposium 2011

The promise of personalized medicine to improve disease understanding and patient outcomes is driving rapid growth in biomarker and translational research. Many groups are facing challenges from the explosion in NGS and other molecular data in combination with siloed clinical data and bottlenecks in accessing bioinformatic and statistical analytics. This signature event provides a forum for debate and discussion around these key challenges and the IT solutions that are changing the face of translational research. The symposium features international experts who are pioneering this new frontier in healthcare.

April 5, 2011, San Francisco, California, USA

World Safety Biomarkers Summit

The Biorbis Safety Biomarkers Summit will bring together industry leaders with a practical, hands-on approach, allowing you to engage in discussion on the practical and regulatory challenges relating to safety biomarker development. This meeting is designed to bring together the pharmaceutical industry, regulators and academics to facilitate shared learning.

March 30 – 31, 2011, Boston, Massachusetts, USA

Companion Diagnostics Summit Europe

This meeting steps away from the larger, more generic biomarker or personalised medicine conferences. The aim is to discuss the opportunities and challenges specifically focused around companion diagnostic development. Because that’s the next crucial step to master if we are going to achieve patient stratification.

March 22 – 24, 2011, Frankfurt, Germany

Biomarkers for Brain Disorders: Challenges and Opportunities

The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. This new Wellcome Trust Scientific Conference will bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs. The meeting will discuss methodological aspects of biomarker identification across a spectrum of psychiatric and neurodegenerative disorders, strategies for diagnostic assay development and pathways for regulatory approval. Specific attention will be given to results from consortia such as the Alzheimer Disease Neuroimaging Initiative (ADNI), and to the prioritization of approaches not yet included in large consortia efforts, such as functional measures of brain activity captured by fMRI or electrophysiological recordings.

Feb 27 – Mar 2, 2011, Hinxton, Cambridge, UK

The 6th Annual Biomarkers Congress

The 6th Annual Biomarkers Congress 2011 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 200 attendees to gain knowledge and insights into the Biomarkers marketplace. The event explores core topics such as discovery & validation strategies, regulatory issues, the key role of personalised medicine and diagnostics, safety biomarkers and biomarkers within clinical development, as well as the integration of applications and enabling technologies such as genomics, microRNA, systems biology to maximise biomarker identification.

Feb 23 – 24, 2011, Manchester, UK

Biomarker Clinical Development Symposium

Quest Diagnostics Clinical Trials is sponsoring a Pre-Event Symposium to the 6th Annual Biomarkers Congress, which will focus on Oncology Biomarker Clinical Development. The complimentary biomarker symposium will focus on oncology and enable participants to optimize biomarker research and development in clinical programs, share best practices and network with colleagues and discuss opportunities and practices that bridge biomarkers into companion diagnostic development.

Feb 22, 2011, Manchester, UK

Biomarker Assay Development

Jan 31 – Feb 2, 2011, San Diego, California, USA

SMi 4th Annual Biomarkers Summit Workshop – Fit for Purpose Biomarkers: From Bench to Bedside

This interactive workshop will highlight the nature and requirements of the different classes of Biomarkers, the technologies most suited to developing Biomarkers, and discuss case studies of Biomarker development and implementation which will help illuminate the key issues which can arrive during the journey from bench to bedside. Hosted by Eric Culbert, Executive Director of BioScience Innovations.

Feb 2, 2011, London, UK

SMi’s 4th Annual Biomarkers Summit – Biomarker Discovery, Validation and Qualification

The conference features twenty eight leading industry experts, the programme features dedicated Oncology, Immunology, and CNS therapeutic streams. Whilst also addressing such key areas as Bioinformatics, Preclinical Biomarker R&D, Translational Biomarkers, and Personalised Medicine.

Jan 31 – Feb 1, 2011, London, UK

GTC 3rd Oncology Biomarkers Conference

This conference focuses on topics paramount to the continuing progress of biomarker research and development. This two-day summit will bring together top leaders from the pharmaceutical and biotechnology communities, officials from the FDA and NIH, and researchers from esteemed academic institutions to discuss the landscape of research, the challenges of regulations, and the future of biomarker opportunities.

Jan 27 – 28, 2011, San Diego, California, USA

Biomarkers in Diagnostics & Therapeutics

This conference provides a platform for industry professionals to discuss the values of incorporating biomarkers into pharmaceuticals and diagnostics development, their potential applications in diseases management such as early prediction and detection of medical conditions as well as in facilitating tailored therapeutics that could be safer and more effective for individuals.

Jan 24 – 25, 2011, Singapore

The Inaugural Biomarker Discovery Conference (BDC 2010)

The Inaugural Biomarker Discovery Conference (BDC 2010) will bring together the latest innovative techniques in Biomarker Discovery using genomic, proteomic and metabolomic tools and methods. Cancer and neurobiology will be important disease themes as the meeting focuses on attempts to discover and exploit biomarker signatures.

Dec 6 – 10, 2010, Port Stephens, New South Wales, Australia

Conference summary (free article in Future Medicine)